SHANGHAI (AP) — China vowed yesterday to crack down on contaminated and sometimes deadly food and drugs after a string of sensational revelations about the safety of Chinese products.
The campaign followed an announcement that authorities had detained managers from two companies linked to contaminated pet food that killed dogs and cats in the United States and Canada.
State press, meanwhile, said the country’s disgraced former top drug regulator would go on trial this month on charges of taking bribes to approve untested medicine.
China has long attracted adverse publicity tied to its notoriously lax enforcement of food and drug safety, but the present round has been especially worrying.
China faces criticism from the United States and the 27-nation European Union for what they contend are unfair trade practices, and tainted-food scandals could lead to bans on food products that would put hard-pressed Chinese farmers under even greater strain.
Already this year, Mississippi and Alabama have banned catfish from China after tests found ciprofloxacin and enrofloxacin, antibiotics banned for use in the United States. Louisiana officials said Monday they would begin testing Chinese seafood for the antibiotics.
China’s government body responsible for overseeing food safety said it had detained an unspecified number of managers from Xuzhou Anying Biologic Technology Development Co. Ltd. and Binzhou Futian Biology Technology Co. Ltd.
That came after the U.S. Food and Drug Administration cited the firms as the source of pet food ingredients tainted with melamine, a chemical used in plastics, fertilizers and fire retardants.
U.S. inspectors said the tainted gluten was used to make pet food and caused the deaths of an unknown number of dogs and cats, sparking a recall of 154 brands of pet food contaminated with the chemical, which artificially boosts nitrogen levels, making products seem higher in protein.
“Relevant departments will deal strictly with the lawbreaking companies and those responsible according to the results of the investigation,” China’s General Administration of Quality Supervision, Inspection and Quarantine said on its Web site.
Separately, the State Council, or Cabinet, said the nationwide food-safety crackdown would compel companies to adopt “standards used in food-importing countries … and test products which will be used to make animal feed or food for humans.”
The government must “strengthen its investigations into protein products, especially melamine,” the notice said.
It said all classes of food and drugs would be subject to more rigorous inspections, with an emphasis on securing the food supply chain and boosting food safety in the vast, mostly impoverished countryside.
In Washington, FDA Commissioner Dr. Andrew von Eschenbach and Chinese Ambassador Zhou Wenzhong told two lawmakers yesterday they would work toward a mutual agreement to improve inspections and the overall safety of food products and drugs traded between the U.S. and China.
That agreement likely would take the form of a memorandum of understanding between the two governments, said Sen. Richard J. Durbin, Illinois Democrat, who convened the meeting with Rep. Rosa DeLauro, Connecticut Democrat.
U.S. officials say they don’t think melamine is harmful to humans, but say they have too little data to determine how it reacts with other substances.
The FDA says it is particularly concerned about the combination of melamine with cyanuric acid, a similar chemical usually used to help keep swimming pools clean but sometimes used as a feed additive. Some U.S. scientists have suggested that combination may have led to the pet deaths through kidney failure.
Sales managers at four Chinese chemical companies said they were unaware of cyanuric acid’s use as a feed additive, although two others said they had heard of the practice but didn’t know how widespread it was.
“As far as I know, it is seldom used in animal feed,” said Chai Zhixian, a salesman with Shanghai Experimental Reagent Co.
The Chinese agency that sets regulator standards for food and drug safety has been in disarray for years. Its director, Zheng Xiaoyu, was dismissed in 2005 and has since been accused of taking up to $780,000 in bribes to approve untested medicines, including an antibiotic that killed at least 10 patients.
Mr. Zheng is scheduled to go on trial in mid-May.
Please read our comment policy before commenting.